2 suspended. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Suspended 2 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR) Aramchol free acid, Placebo - Nonalcoholic Steatohepatitis (NASH) | Phase 3 | Suspended | Galmed Research and Development, Ltd. | 157 | 2019-09-23 | 2026-02-11 |
| Acetaminophen Dosing in Obese Adolescents Tylenol - Obesity, Childhood | Phase 3 | Suspended | Children's National Research Institute | 6 | 2016-08-01 | 2024-08-22 |
Obesity (2) · Diabetes Mellitus (1) · Fibrosis (1) · Liver Cirrhosis (1) · Non-alcoholic Fatty Liver Disease (1) · Pediatric Obesity (1)
Body Weight (2) · Nutrition Disorders (2) · Nutritional and Metabolic Diseases (2) · Overnutrition (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Fatty Liver (1) · Glucose Metabolism Disorders (1) · Liver Diseases (1) · Metabolic Diseases (1) · Pathologic Processes (1)
Acetaminophen (1)
Children's National Research Institute (1) · Galmed Research and Development, Ltd. (1)
United States (2)
Yossi Gilgun-Sherki, PhD, MBA (1)
PMID 12434728, PMID 18987268, PMID 22253363, PMID 22253364, PMID 22389380, PMID 22768009, PMID 38916482, PMID 8403734, PMID 9874695